vimarsana.com

சர்வதேச கூட்டமைப்பு ஆஃப் தடுப்பூசி உற்பத்தியாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MEPs threaten TRADE WAR with UK over vaccine supplies

Nicola Sturgeon is accused of taking the EU s side and risking vaccine rollout as she vows to publish details of UK s supplies despite Boris Johnson ordering her to keep them secret - as Brussels claims AstraZeneca is giving Britain too much European Commission said AstraZeneca is obliged to meet contractual agreement to supply vaccines to EU EU s health commissioner insisted that UK should not receive priority, despite placing order months earlier Astra-Zeneca warned EU it would only receive quarter of the  100million doses it expected to have by April But firm stuck to its guns, saying it had been open with EU chiefs over complexities of scaling up production

Coronavirus: France s Sanofi to help rival Pfizer-BioNTech make vaccines

In an unusual and potentially groundbreaking decision, French drugmaker Sanofi said it will help bottle and package 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech, while its own vaccine candidate faces delays. The announcement came as delays or production problems for the Pfizer-BioNTech vaccine and a vaccine from Britain s AstraZeneca have caused political uproar across the European Union. READ MORE: French drug maker Sanofi said it will help manufacture 125 million doses of the coronavirus vaccine developed by rivals Pfizer and BioNTech, while its own vaccine candidate faces delays.(AP) The EU s 27-nation vaccination effort has struggled to pick up steam, while more contagious virus variants are spreading fast and COVID-19 deaths are surging anew.

France s Sanofi to aid rival Pfizer s vaccine effort; EU critical of AstraZeneca

France s Sanofi to aid rival Pfizer s vaccine effort; EU critical of AstraZeneca Issued on: 28/01/2021 - 14:35 EU Commission chief Ursula von der Leyen has put pressure on pharmaceutical firms to deliver on their vaccine promises. Handout World Economic Forum (WEF)/AFP Text by: Jan van der Made with RFI 5 min In an unusual and potentially groundbreaking decision, French drugmaker Sanofi has said it will help bottle and package 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech, while development of Sanofi s own vaccine faces delays. Meanwhile, tensions between the EU and vaccine maker AstraZeneca are growing after the company rejected Brussel s accusation it was late with its delivery of the drug. 

France s Sanofi to help rival Pfizer-BioNTech make coronavirus vaccines

In an unusual and potentially groundbreaking decision, French drugmaker Sanofi said Wednesday it will help bottle and package 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech, while its own vaccine candidate faces delays. The announcement came as delays or production problems for the Pfizer-BioNTech vaccine and a vaccine from Britain s AstraZeneca have caused political uproar across the European Union. The EU s 27-nation vaccination effort has struggled to pick up steam, while more contagious virus variants are spreading fast and COVID-19 deaths are surging anew. Sanofi s Frankfurt facilities will help with late-stage production of vaccines prepared by Germany-based BioNTech, including bottling and packaging, starting in the summer, according to a Sanofi official. Sanofi did not reveal financial details of the agreement.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.